Walgreens Boots Alliance reported a 2.6% increase in sales to $36.4 billion for the third quarter of fiscal year 2024. However, adjusted EPS decreased by 36.6% to $0.63, impacted by lower sale-leaseback gains and a challenging U.S. retail environment. The company is lowering its fiscal year 2024 adjusted EPS guidance to $2.80 to $2.95.
Third quarter sales increased 2.6% year-over-year to $36.4 billion.
Adjusted EPS was $0.63, a 36.6% decrease compared to the prior year.
Lowering fiscal 2024 adjusted EPS guidance to $2.80 to $2.95.
Strategic review underway to optimize footprint and improve customer experience.
Walgreens is lowering its fiscal 2024 adjusted EPS guidance to $2.80 - $2.95, reflecting persistent pressures on the U.S. consumer and the impact of recent marketplace dynamics which have eroded pharmacy margins.
Visualization of income flow from segment revenue to net income